Abstract:Spinal cord injury (SCI) results in multiple pathophysiological processes, including blood–spinal cord barrier disruption, hemorrhage/ischemia, oxidative stress, neuroinflammation, scar formation, and demyelination. These responses eventually lead to severe tissue destruction and an inhibitory environment for neural regeneration.cAMP signaling is vital for neurite outgrowth and axonal guidance. Stimulating intracellular cAMP activity significantly promotes neuronal survival and axonal regrowth after SCI.However, neuronal cAMP levels in adult CNS are relatively low and will further decrease after injury. Targeting cAMP signaling has become a promising strategy for neural regeneration over the past two decades. Furthermore, studies have revealed that cAMP signaling is involved in the regulation of glial cell function in the microenvironment of SCI, including macrophages/microglia, reactive astrocytes, and oligodendrocytes. cAMP-elevating agents in the post-injury milieu increase the cAMP levels in both neurons and glial cells and facilitate injury repair through the interplay between neurons and glial cells and ultimately contribute to better morphological and functional outcomes. In recent years, combination treatments associated with cAMP signaling have been shown to exert synergistic effects on the recovery of SCI. Agents carried by nanoparticles exhibit increased water solubility and capacity to cross the blood–spinal cord barrier. Implanted bioscaffolds and injected hydrogels are potential carriers to release agents locally to avoid systemic side effects. Cell transplantation may provide permissive matrices to synergize with the cAMP-enhanced growth capacity of neurons. cAMP can also induce the oriented differentiation of transplanted neural stem/progenitor cells into neurons and increase the survival rate of cell grafts. Emerging progress focused on cAMP compartmentation provides researchers with new perspectives to understand the complexity of downstream signaling, which may facilitate the clinical translation of strategies targeting cAMP signaling for SCI repair.

Advances of the MAPK pathway in the treatment of spinal cord injury

PI3 Kinase Regulation of Neural Regeneration and Muscle Hypertrophy after Spinal Cord Injury

Inflammation & apoptosis in spinal cord injury.

A Brief Summary of Current Therapeutic Strategies for Spinal Cord Injury

Spinal cord injury: molecular mechanisms and therapeutic interventions

Recent advances on signaling pathways and their inhibitors in spinal cord injury

Current Knowledge of Microglia in Traumatic Spinal Cord Injury

Recent progress and challenges in the treatment of spinal cord injury

Multifaceted Roles of cAMP Signaling in the Repair Process of Spinal Cord Injury and Related Combination Treatments

Mesenchymal stem cells in the treatment of spinal cord injury: Mechanisms, current advances and future challenges

Neuroinflammation and Scarring After Spinal Cord Injury: Therapeutic Roles of MSCs on Inflammation and Glial Scar

Wnt signaling pathway in spinal cord injury: from mechanisms to potential applications

Progression of mesenchymal stem cell regulation on imbalanced microenvironment after spinal cord injury

Mechanism and prospects of mitochondrial transplantation for spinal cord injury treatment

Multipotent Mesenchymal Stem Cell-Based Therapies for Spinal Cord Injury: Current Progress and Future Prospects

Microenvironments‐Modulated Biomaterials Enhance Spinal Cord Injury Therapy

Current Treatments after Spinal Cord Injury: Cell Engineering, Tissue Engineering, and Combined Therapies

TGF‐β signaling pathway in spinal cord injury: Mechanisms and therapeutic potential

Research Advances of Biomaterials-Based Microenvironment-Regulation Therapies for Repair and Regeneration of Spinal Cord Injury

Translational Relevance of Secondary Intracellular Signaling Cascades Following Traumatic Spinal Cord Injury